India, Oct. 20 -- Immuna Therapeutics AG, based in, Switzerland, and NIMS University Rajasthan, Jaipur, have announced a $3 million partnership to develop an affordable, locally delivered model for CAR-T cell therapy in Rajasthan.

Announced at the World Health Summit in Berlin, the collaboration aims to establish a Rajasthan Centre of Excellence for CAR-T clinical delivery, research and training.

Signed in the presence of Prof. (Dr) Balvir S. Tomar, Founder and Chancellor of NIMS University, and Pradeep Kakkattil the Co-founder of Immuna Therapeutics and Founder & CEO of Health Innovation Exchange - HIEx, the partnership is intended to create a scalable model that could extend access to advanced cancer treatments beyond major metropolit...